Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures

Reaction to Avandia warnings stronger among internists than endocrinologists, according to study by GfK Market Measures. (Graphic: Business Wire)

Internists will switch more than half their patients currently on Avandia to another therapy, following the published NEJM warnings about Avandia, according to study by GfK Market Measures. (Graphic: Business Wire)